Cite
HARVARD Citation
Stensen, S. et al. (2022). Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Diabetes, obesity & metabolism. 24 (9), pp. 1882-1887. [Online].